These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 17889536

  • 1. Conformationally restricted macrocyclic analogues of combretastatins.
    Mateo C, Alvarez R, Pérez-Melero C, Peláez R, Medarde M.
    Bioorg Med Chem Lett; 2007 Nov 15; 17(22):6316-20. PubMed ID: 17889536
    [Abstract] [Full Text] [Related]

  • 2. p,p-Dihydroxydihydrostilbenophanes related to antimitotic combretastatins. Conformational analysis and its relationship to tubulin inhibition.
    Álvarez R, López V, Mateo C, Medarde M, Peláez R.
    J Org Chem; 2014 Aug 01; 79(15):6840-57. PubMed ID: 24966024
    [Abstract] [Full Text] [Related]

  • 3. New naphthylcombretastatins. Modifications on the ethylene bridge.
    Sánchez Maya AB, Pérez-Melero C, Salvador N, Peláez R, Caballero E, Medarde M.
    Bioorg Med Chem; 2005 Mar 15; 13(6):2097-107. PubMed ID: 15727863
    [Abstract] [Full Text] [Related]

  • 4. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity.
    Medarde M, Maya AB, Pérez-Melero C.
    J Enzyme Inhib Med Chem; 2004 Dec 15; 19(6):521-40. PubMed ID: 15662956
    [Abstract] [Full Text] [Related]

  • 5. Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly.
    Ducki S, Mackenzie G, Lawrence NJ, Snyder JP.
    J Med Chem; 2005 Jan 27; 48(2):457-65. PubMed ID: 15658859
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins.
    Alvarez C, Alvarez R, Corchete P, Pérez-Melero C, Peláez R, Medarde M.
    Bioorg Med Chem Lett; 2007 Jun 15; 17(12):3417-20. PubMed ID: 17434303
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and conformational analysis of macrocyclic dihydroxystilbenes linked between the para-para positions.
    Mateo C, López V, Medarde M, Peláez R.
    Chemistry; 2007 Jun 15; 13(25):7246-56. PubMed ID: 17566133
    [Abstract] [Full Text] [Related]

  • 8. Isocombretastatins A: 1,1-diarylethenes as potent inhibitors of tubulin polymerization and cytotoxic compounds.
    Alvarez R, Alvarez C, Mollinedo F, Sierra BG, Medarde M, Peláez R.
    Bioorg Med Chem; 2009 Sep 01; 17(17):6422-31. PubMed ID: 19647439
    [Abstract] [Full Text] [Related]

  • 9. New para-para stilbenophanes: synthesis by McMurry coupling, conformational analysis and inhibition of tubulin polymerisation.
    Álvarez R, López V, Mateo C, Medarde M, Peláez R.
    Chemistry; 2011 Mar 14; 17(12):3406-19. PubMed ID: 21344518
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and evaluation of double bond substituted combretastatins.
    Hadfield JA, Gaukroger K, Hirst N, Weston AP, Lawrence NJ, McGown AT.
    Eur J Med Chem; 2005 Jun 14; 40(6):529-41. PubMed ID: 15922837
    [Abstract] [Full Text] [Related]

  • 11. Structural requirements for the interaction of combretastatins with tubulin: how important is the trimethoxy unit?
    Gaukroger K, Hadfield JA, Lawrence NJ, Nolan S, McGown AT.
    Org Biomol Chem; 2003 Sep 07; 1(17):3033-7. PubMed ID: 14518125
    [Abstract] [Full Text] [Related]

  • 12. Isocombretastatins a versus combretastatins a: the forgotten isoCA-4 isomer as a highly promising cytotoxic and antitubulin agent.
    Messaoudi S, Tréguier B, Hamze A, Provot O, Peyrat JF, De Losada JR, Liu JM, Bignon J, Wdzieczak-Bakala J, Thoret S, Dubois J, Brion JD, Alami M.
    J Med Chem; 2009 Jul 23; 52(14):4538-42. PubMed ID: 19530698
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and cytotoxic activity of a new group of heterocyclic analogues of the combretastatins.
    Lipeeva AV, Shults EE, Shakirov MM, Pokrovsky MA, Pokrovsky AG.
    Molecules; 2014 Jun 11; 19(6):7881-900. PubMed ID: 24962392
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Design, synthesis, biological evaluation and molecular modeling study of novel macrocyclic bisbibenzyl analogues as antitubulin agents.
    Sun B, Li L, Hu QW, Zheng HB, Tang H, Niu HM, Yuan HQ, Lou HX.
    Eur J Med Chem; 2017 Mar 31; 129():186-208. PubMed ID: 28222318
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, anticancer activity, and inhibition of tubulin polymerization by conformationally restricted analogues of lavendustin A.
    Mu F, Hamel E, Lee DJ, Pryor DE, Cushman M.
    J Med Chem; 2003 Apr 24; 46(9):1670-82. PubMed ID: 12699385
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
    Hall JJ, Sriram M, Strecker TE, Tidmore JK, Jelinek CJ, Kumar GD, Hadimani MB, Pettit GR, Chaplin DJ, Trawick ML, Pinney KG.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5146-9. PubMed ID: 18710804
    [Abstract] [Full Text] [Related]

  • 18. Novel Combretastatin-2-aminoimidazole Analogues as Potent Tubulin Assembly Inhibitors: Exploration of Unique Pharmacophoric Impact of Bridging Skeleton and Aryl Moiety.
    Chaudhary V, Venghateri JB, Dhaked HP, Bhoyar AS, Guchhait SK, Panda D.
    J Med Chem; 2016 Apr 14; 59(7):3439-51. PubMed ID: 26938120
    [Abstract] [Full Text] [Related]

  • 19. Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents.
    ter Haar E, Rosenkranz HS, Hamel E, Day BW.
    Bioorg Med Chem; 1996 Oct 14; 4(10):1659-71. PubMed ID: 8931935
    [Abstract] [Full Text] [Related]

  • 20. Syntheses and bioactivities of macrocyclic paclitaxel bis-lactones.
    Liu C, Schilling JK, Ravindra R, Bane S, Kingston DG.
    Bioorg Med Chem; 2004 Dec 01; 12(23):6147-61. PubMed ID: 15519159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.